Stock RLF RELIEF THERAPEUTICS HOLDING SA
Add to a list
To use this feature you must be a member
Log inSign up

Company Relief Therapeutics Holding SA

Equities

RLF

CH1251125998

Biotechnology & Medical Research

End-of-day quote Swiss Exchange
Other stock markets
 06:00:00 2024-04-16 pm EDT 		5-day change 1st Jan Change
1.215 CHF -3.57% Intraday chart for Relief Therapeutics Holding SA -5.45% -38.94%
Mar. 22 Sector Update: Health Care Stocks Steady Pre-Bell Friday MT
Mar. 22 Sector Update: Health Care MT

Business Summary

RELIEF THERAPEUTICS Holding SA is a Switzerland-based biopharmaceutical company. The Company’s objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need, as well as to focus on developing treatments for respiratory diseases. It specializes in clinical-stage projects based on molecules of natural origin (peptides and proteins with a history of clinical use and either initial human activity with efficacy data or a strong scientific rationale. Its lead compound is RLF-100 (aviptadil), a synthetic human vasoactive intestinal peptide (VIP) with a multifaceted mode of action in respiratory indications. RLF-100 is being investigated in two placebo-controlled U.S. phase 2b/3 clinical trials in respiratory deficiency due to COVID-19. Its RLF-100 is also used for pulmonary sarcoidosis. The Company is also involved in the clinical development of RLF-100 that is in planning stage for other indications in acute and chronic lung diseases.

Number of employees: 69

Sales per Business

CHF in Million2021Weight2022Weight Delta
Biopharmaceutical Products
100.0 %
3 100.0 % 6 100.0 % +83.11%

Sales per region

CHF in Million2021Weight2022Weight Delta
Europe (excluding Switzerland)
39.7 %
1 33.6 % 2 39.7 % +116.32%
North America
27.9 %
1 25.1 % 2 27.9 % +103.47%
Rest of the World
19.2 %
1 25.4 % 1 19.2 % +38.63%
Switzerland
13.2 %
1 15.9 % 1 13.2 % +51.80%

Managers

Managers TitleAgeSince
Michelle Lock CEO
 Chief Executive Officer - 22-01-27
Jeremy Meinen DFI
 Director of Finance/CFO - -
Ram Selvaraju CHM
 Chairman 46 16-05-24
Paolo Galfetti COO
 Chief Operating Officer - 21-05-26
Anthony M. Kim PRN
 Corporate Officer/Principal - 21-11-30
Marco Marotta PRN
 Corporate Officer/Principal - 21-11-29

Members of the board

Members of the board TitleAgeSince
Ram Selvaraju CHM
 Chairman 46 16-05-24
Paolo Galfetti COO
 Chief Operating Officer - 21-05-26
Thomas Plitz BRD
 Director/Board Member 56 20-12-16
Patrice Jean BRD
 Director/Board Member - 21-05-26
Michelle Lock CEO
 Chief Executive Officer - 22-01-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 14,040,837 9,248,182 ( 65.87 %) 1,822,398 ( 12.98 %) 65.87 %

Shareholders

NameEquities%Valuation
Global Emerging Markets North America, Inc.
20.58 %
2,889,748 20.58 % 4 M CHF
RELIEF THERAPEUTICS HOLDING SA
12.98 %
1,822,398 12.98 % 3 M CHF
Armistice Capital LLC
8.546 %
1,200,000 8.546 % 2 M CHF
Herculis Partners SA
0.5876 %
82,500 0.5876 % 119 074 CHF
Paolo Galfetti
0.5562 %
78,093 0.5562 % 112 713 CHF
British & American Investment Trust Plc (Invt Mgmt)
0.0323 %
4,541 0.0323 % 6 554 CHF
DWS CH AG
0.0181 %
2,535 0.0181 % 3 659 CHF
Thomas Plitz
0.008903 %
1,250 0.008903 % 1 804 CHF
Jack M. Weinstein
0.003290 %
462 0.003290 % 667 CHF
State Street Global Advisors France SA
0.003084 %
433 0.003084 % 625 CHF

Holdings

NameEquities%Valuation
RELIEF THERAPEUTICS HOLDING SA
12.98%
 1,822,398 12.98% 2,630,303 $

Company contact information

RELIEF THERAPEUTICS Holding SA

Avenue de Sécheron 15 Bâtiment F2/F3

1202, Geneva

+

http://www.relieftherapeutics.com
address Relief Therapeutics Holding SA(RLF)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per region

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
RELIEF THERAPEUTICS HOLDING SA Stock Relief Therapeutics Holding SA
-38.94% 16.7M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-1.78% 41.36B
LONZA GROUP AG Stock Lonza Group AG
+45.04% 41.3B
MODERNA, INC. Stock Moderna, Inc.
+4.01% 39.61B
CELLTRION, INC. Stock Celltrion, Inc.
-15.14% 25.62B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+3.16% 24.09B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.08% 18.38B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-2.67% 11.82B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+24.76% 11.85B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+7.01% 11.07B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. RLF Stock
  4. Company Relief Therapeutics Holding SA